Latest Trials

EudraCT Number: 2004-000767-10

Sponsor Protocol Number: V82P1

Start Date: 2004-06-29

Sponsor Name: CHIRON

Full Title: A Phase I/II, Single Center, Partially Observer-Blind, Controlled, Randomized Study to Explore Safety and Immunogenicity in Healthy Adult Subjects who Receive Either One Dose of Chiron Combined Men...

Medical condition: Active immnunisation for the prevention of invasive disease caused by N. Meningitidis serogroup C and H. influenzae type b

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10027249		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000609-23

Sponsor Protocol Number: BXL-6280213

Start Date: 2004-06-25

Sponsor Name: BIOXELL SPA

Full Title: A randomized, double blind, placebo controlled, parallel-group study to determine the effect of BXL-628 in post-menopausal women with Overactive Bladder (OAB)

Medical condition: overactive bladder

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10027300		HLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000206-31

Sponsor Protocol Number: C1 1304-01

Start Date: 2004-06-22

Sponsor Name: PHARMING TECHNOLOGIES B.V.

Full Title: A randomized, placebo-controlled, double-blind Phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

Medical condition: hereditary angioedema (HAE) treatment

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10019860	Hereditary angioedema	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) GB (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001301-10

Sponsor Protocol Number: EOP1009

Start Date: 2004-06-14

Sponsor Name: PFIZER

Full Title: A PHASE II PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, DOSE-RANGING, MULTI-CENTER TRIAL TO ASSESS THE EFFECT OF PEGAPTANIB SODIUM ON FOVEAL THICKENING IN PATIENTS WITH EXUDATIVE SUBFOV...

Medical condition: AGE-RELATED MACULAR DEGENERATION

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10025409		PT

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000603-18

Sponsor Protocol Number: Q10DOWN

Start Date: 2004-06-11

Sponsor Name: AZIENDA OSPEDALIERA UMBERTO I

Full Title: ubiquinone in Down syndrome

Medical condition: Down syndrome

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000507-17

Sponsor Protocol Number: SC1-04

Start Date: 2004-06-10

Sponsor Name: FONDAZIONE SANTA LUCIA

Full Title: Effectiveness of rivastigmine treatment in post-stroke patients with right brain damage and unilateral spatial neglect

Medical condition: Improvement of unilateral spatial neglect and functional status in right brain damaged patients

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000782-35

Sponsor Protocol Number: CERL080AIT06

Start Date: 2004-06-10

Sponsor Name: NOVARTIS FARMA

Full Title: EVALUATION OF THE QUALITY OF LIFE AND GASTROINTESTINAL SYMPTOMS AFTER CONVERSION TO MYFORTIC (ERL080) and CELLCEPT WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS.

Medical condition: Prophylaxis of transplant rejection in adult patients receiving calcineurin inhibitors with / without corticosteroids after allogeneic renal transplants.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10023439		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000374-31

Sponsor Protocol Number: SB-683699/003

Start Date: 2004-06-09

Sponsor Name: GLAXO SMITHKLINE

Full Title: A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-Ranging Study to Investigate the Efficacy and Safety of Three Months administration of SB 683699 (150 - 1200mg twice daily) in ...

Medical condition: Relapsing Multiple Sclerosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2009-017840-15

Sponsor Protocol Number: KS-2003-06

Start Date: 2004-05-31

Sponsor Name: DSC Services, s.r.o.

Full Title: Srovnání účinnosti kapecitabinu (Xeloda) s kontinuálním podáním 5-fluorouracilu v předoperační konkomitantní léčbě s radioterapií u karcinomu rekta

Medical condition: Rectal cancer stage II and III

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000376-14

Sponsor Protocol Number: CLAF237A2309

Start Date: 2004-05-28

Sponsor Name: NOVARTIS FARMA

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED STUDY TO COMPARE THE EFFECT OF 52 WEEKS TREATMENT WITH LAF237 50 MG BID TO METFORMIN UP TO 1000 MG BID IN DRUG NAIVE PATIENTS WITH TYPE 2 ...

Medical condition: MONOTHERAPY TREATMENT OF PATIENTS WITH TYPE 2 DIABETES

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012601		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions